Can higher hematocrit and red-cell mass impair microvascular blood flow?

Higher hematocrit/red-cell mass is a biologically and clinically meaningful driver of hyperviscosity. In a 77-year-old man, interpretation remains individualized: hematocrit reflects both red-cell mass and plasma volume, while vascular reserve and comorbid disease can influence clinical consequences.

Hemorheology and clinical evidence

• Hematocrit is a dominant determinant of whole-blood viscosity. The increase is nonlinear, becoming disproportionately greater at low shear rates and at hematocrits above approximately 45–50%.
• Intervention data in polycythemia vera show that phlebotomy-induced reduction in red-cell mass significantly lowers whole-blood viscosity at both low and high shear, with little change in plasma viscosity—supporting a causal role of erythrocyte excess.
• In polycythemia vera, maintaining hematocrit below 45% versus 45–50% produced markedly fewer cardiovascular deaths or major thrombotic events. This is clinically important, though these outcomes are not direct measurements of microvascular flow.

Microvascular effects and mechanisms

• Increased viscosity can impede microvascular perfusion, particularly in clinically significant erythrocytosis or hyperviscosity states. Potential manifestations include headache, dizziness, visual symptoms, paresthesia, erythromelalgia, and cognitive symptoms.
• Higher hematocrit promotes erythrocyte aggregation: rouleaux density, length, and cell–cell interactions increase. At low shear, fibrinogen/protein-mediated rouleaux and network structures further raise apparent viscosity.
• Red-cell deformability is also critical. Less deformable erythrocytes traverse capillaries poorly and can impair tissue perfusion independently of hematocrit.
• Polycythemia vera has been associated with lower retinal, choroidal, optic-nerve-head, and macular vessel density, with preliminary angiographic evidence of delayed ocular flow.

Clinical interpretation

• Microvascular effects vary by vascular bed because autoregulation, plasma skimming, cell-free layers, and the Fåhraeus–Lindqvist effect can partly buffer increased viscosity.

Bottom line

• The claim is supported: elevated hematocrit/red-cell mass increases whole-blood viscosity and can impair microvascular blood flow, especially at higher hematocrit and low shear, although individual impact depends on plasma volume and red-cell rheology.